PUBLIKATIONSLISTE  PD Dr. Michael Knauer PhD

 

 

 

I. Originalien

 

 

 

1.     Knauer M, Konstantiniuk P, Haid A, Wenzl E, Riegler-Keil M, Pöstlberger S, Reitsamer R, Schrenk P (2006): Multicentric breast cancer: a new indication for sentinel node biopsy--a multi-institutional validation study; J Clin Oncol.24(21):3374-80. JIF 2011: 18,372

 

2.     Knauer M, Haid A, Schneider Y, Köberle-Wührer R, Lang A, Winder T, Alton R, Jasarevic Z, Säly C, Offner FA, Wenzl E, Devries A (2009): Adjuvant extension of chemotherapy after neoadjuvant therapy may not improve outcome in early-stage breast cancer; Eur J Surg Oncol. 35(8):798-804. Epub 2008 Nov 14. JIF 2011: 2,499

 

3.     Knauer M, Wenzl E, Rutgers EJT, Linn SC, van ‘t Veer LJ (2009): Gene expression profiling in breast cancer – design of a pooled database to address open questions; Eur Surg. 41(5):221-227. JIF 2011: 0,283

 

4.     Knauer M, Mook S, Rutgers EJ, Bender RA, Hauptmann M, van de Vijver MJ, Koornstra RH, Bueno-de-Mesquita JM, Linn SC, van 't Veer LJ (2010): The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer; Breast Cancer Res Treat. 120(3):655-61. Epub 2010 Mar 5. JIF 2011: 4,431

 

5.     Mook S, Knauer M (contributed equally), Bueno-de-Mesquita JM, Retel VP, Wesseling J, Linn SC, van ‘t Veer LJ, Rutgers EJT (2010): Metastatic Potential of T1 Breast Cancer can be Predicted by the 70-gene MammaPrint Signature; Ann Surg Oncol. 17(5):1406-13. Epub 2010 Jan 22. JIF 2011: 4,166

 

6.     Knauer M, Cardoso F, Wesseling J, Bedard PL, Linn SC, Rutgers EJT, van ‘t Veer LJ (2010): Identification of a low risk subgroup of HER-2 positive breast cancer by the 70-gene prognosis signature: Br J Cancer. 2010 Dec 7;103(12):1788-93. Epub 2010 Nov 16. JIF 2011: 5,042

 

7.     Knauer M, Gnant M, Fitzal F (2012): Results of the First Austrian Multidisciplinary Expert Panel on Controversies in Local Treatment of Breast Cancer: Breast Care. 7:61-66. Epub 2012 Feb 20. JIF 2011: 0,446

 

8.     Knauer M, Filipits M, Dubsky P (2014): Late Recurrences in Early Breast Cancer: For

 

Whom and How Long is Endocrine Therapy Beneficial?: Breast Care (in press)

 

9.     Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H, Zimmermann G (2002): Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation; Breast Cancer Res Treat. 73(1):31-6. JIF 2011: 4,431

 

10.  Haid A, Kuehn T, Konstantiniuk P, Koberle-Wuhrer R, Knauer M, Kreienberg R, Zimmermann G (2002): Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer; Eur J Surg Oncol. 28(7):705-10. JIF 2011: 2,499

 

11.  Haid A, Knauer M, Koberle-Wuhrer R, Ammann K, Koller L, Eiter H,Lang A,Wenzl E (2006): Medium-term follow-up data after sentinel node biopsy alone for breast cancer; Eur J Surg Oncol.32(10):1180-5. Epub 2006 Jun 5. JIF 2011: 2,499

 

12.  Haid A, Knauer M, Dunzinger S, Jasarevic Z, Koberle-Wuhrer R, Schuster A, Toepker M, Haid B, Wenzl E, Offner F (2007): Intra-operative Sonography: A Valuable Aid During Breast-Conserving Surgery for Occult Breast Cancer; Ann Surg Oncol. 14(11):3090-101. JIF 2011: 4,166

 

13.  Winder T, Mündlein A, Rhomberg S, Dirschmid K, Hartmann BL, Knauer M, Drexel H, Wenzl E, De Vries A, Lang A (2009): Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer; Oncol Rep. 21(5):1283-7. JIF 2011: 1,835

 

14.  Retèl VP, Joore MA, Knauer M, Linn SC, Hauptmann M, Harten WH (2010): Cost-effectiveness of the 70-gene signature versus Sankt Gallen guidelines and Adjuvant Online for early breast cancer; Eur J Cancer. 46(8):1382-91. Epub 2010 Mar 30. JIF 2011: 5,536

 

15.  Esserman LJ, Shieh Y, Rutgers EJ, Knauer M, Retèl VP, Mook S, Glas AM, Moore DH, Linn S, van Leeuwen FE, van 't Veer LJ (2011): Impact of mammographic screening on the detection of good and poor prognosis breast cancers; Breast Cancer Res Treat. 130(3):725-34. Epub 2011 Sep 4. JIF 2011: 4,431

 

16.  Berghoff A, Bago-Horvath Z, De Vries C, Dubsky P, Pluschnig U, Rudas M, Rottenfusser A, Knauer M, Eiter H, Fitzal F, Dieckmann K, Mader RM, Gnant M, Zielinski CC, Steger GG, Preusser M, Bartsch R (2012): Brain metastases free survival differs between breast cancer subtypes; Br J Cancer 31;106(3):440-6. doi: 10.1038/bjc.2011.597. Epub 2012 Jan 10. JIF 2011: 5,042

 

17.  Langsteger W, Haim S, Knauer M, Waldenberger P, Emmanuel K, Loidl W, Wolf I, Beheshti M (2012).: Imaging of bone metastases in prostate cancer: an update; Q J Nucl Med Mol Imaging 56(5):447-58 JIF 2011: 2,256

 

18.    Drukker C, Bueno-de-Mesquita J, Retèl V, van Harten W, van Tinteren H, Wesseling J Roumen R, Knauer M, van 't Veer LJ, Sonke G, Rutgers EJT, van de Vijver M, Linn S (2013): A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study: Int J cancer 133(4):929-36. JIF 2011: 5,444

 

19.    Retèl VP, Joore MA, Drukker CA, Bueno-de-Mesquita JM, Knauer M, van Tinteren H, Linn SC, van Harten WH (2013): Prospective cost-effectiveness analysis of genomic profiling in breast cancer: Eur J Cancer 49(18):3773-9

 

20.    Gnant M, Filipits M, Greil R, Stoeger H, Rudas M, Bago-Horvath Z, Mlineritsch B, Kwasny W, Knauer M, Singer C, Jakesz R, Dubsky P, Fitzal F, Bartsch R, Steger G, Balic M, Ressler S, Cowens JW, Storhoff J, Ferree S, Schaper C, Liu S, Fesl C, Nielsen TO; Austrian Breast and Colorectal Cancer Study Group (2014): Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone: Ann Oncol 25(2):339-45.

 

21.    Filipits M, Nielsen TO, Rudas M, Greil R, Stöger H, Jakesz R, Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C, Müller-Holzner E, Singer CF, Mlineritsch B, Dubsky P, Bauernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper C, Ferree S, Liu S, Cowens JW, Gnant M; Austrian Breast and Colorectal Cancer Study Group (2014): The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer: Clin Cancer Res 20(5):1298-305.

 

Impact Factor gesamt (28.1.2013): 73,378

 

 

 

II. Übersichtsartikel, Fallberichte

 

 

 

1.     Knauer M, Haid A, Köberle-Wührer R, Wenzl E (2004):Verlässlich, minimal invasiv, mit geringer Morbidität. Die Sentinel Node Biopsy beim Mammakarzinom als neuer Therapiestandard;Wien Klin. Wochenschr. Magazin 19-20a:28-31.

 

2.     Knauer M, Haid A, Gruber-Mosenbacher U, Wenzl E (2005): Mesenteric inflammatory veno-occlusive disease (MIVOD)--a rare cause of intestinal ischemia; Wien Klin Wochenschr. 117(17):610-4.

 

3.     Knauer M, Haid A, Ammann K, Lang A, Offner F, Tuertscher M, Cerkl P, Wenzl E (2007): Complications after oesophagectomy with possible contribution of neoadjuvant therapy including an EGFR-antibody to a fatal outcome; World J Surg Oncol. 2007 Oct 11;5(1):114.

 

4.     Knauer M (2009): Zukunft oder neuer diagnostischer Standard? Genexpressionsprofile bei Brustkrebs; Spectrum Onkologie 4/09:34-36.

 

5.     Knauer M (2010): Genexpressionsprofile beim Mammakarzinom – Wachsende Anforderungen an die interdisziplinäre Zusammenarbeit; Jatros Hämatologie & Onkologie 3/10:38-39.

 

6.     Knauer M (2010): Brustgesundheit – Chirurgische Therapie; Universum Innere Medizin 10/10:63-64.

 

7.     Knauer M (2011): Das frühe Mammakarzinom – Diagnostik und Therapie; Die Punkte, in press

 

8.     Haid A, Knauer M, Koberle-Wuhrer R, Wenzl E (2005): Sentinel node biopsy in breast cancer: techniques and indications; Wien Klin Wochenschr. 117(4):121-8

 

 

 

III. Letters to the Editor, Editorials, Kommentare etc.

 

 

 

1.     Knauer M, Devries A, Wenzl E, Haid A (2008): Standardization of pathologic complete response rates in breast cancer treatment; Breast Cancer Res Treat. 2008 Jul;110(2):395-6. Epub 2007 Sep 13.

 

 

 

IV. Bücher, Buchbeiträge, Proceedings

 

 

 

1.     Knauer M, Konstantiniuk P, Haid A, Wenzl E, Köberle-Wührer R, Riegler-Keil M, Pöstlberger S, Reitsamer R, Schrenk P (2008): Multicentric Breast Cancer: Sentinel Node Biopsy as a Diagnostic Tool. In: Hayat (ed.). Methods of Cancer Diagnosis, Therapy, and Prognosis; 1:pp. 99-108. DOI 10.1007/978-1-4020-8369-3, ISBN 978-1-4020-8368-6 (Print) 978-1-4020-8369-3 (Online)

 

 

 

V. Abstracts/Vorträge mit Publikationen

 

 

 

1.     Knauer M, Haid A, Köberle-Wührer R, Bammer T, Zimmermann G (2003): Die Sentinel Node Biopsy beim Mammakarzinom als neuer Therapiestandard – ein verlässliches Verfahren mit geringer Morbidität: Nachsorgeergebnisse von 150 Patientinnen nach alleiniger Wächterlymphknotenbiopsie; Eur Surg. 35:Suppl:Abstr.374.

 

2.     Knauer M, Haid A, Köberle-Wührer R, Zimmermann G (2004): Stellenwert der subareolären Farbstoffinjektion zur Sentinel Node Biopsy: Eigene Erfahrungen und Literaturübersicht; Eur Surg. 36:Suppl 198:41.

 

3.     Knauer M, Konstantiniuk P, Haid A, Schrenk P, Roka S, Pöstlberger S, Rudas M, Wenzl E (2005): Soll der intraoperative Gefrierschnitt bei der Sentinel-Node-Biopsie beim Mammakarzinom Standard bleiben?; Eur Surg. 37:Suppl 203:6.

 

4.     Knauer M, Haid A, Gruber-Mösenbacher U, Wenzl E (2005): Mesenteric inflammatory veno-occlusive disease (MIVOD) im Rahmen von rezidivierenden venösen Thrombosen als seltene Ursache für intestinale Ischämie; Eur Surg.37:Suppl 203:116.

 

5.     Knauer M, Konstantiniuk P, Haid A, Riegler-Keil M, Janauer M, Reitsamer R, Wenzl E, Schrenk P (2006): Das Multizentrische Mammakarzinom als neue Indikation zur Sentinel Node Biopsy; Eur Surg. Suppl 209:20.

 

6.     Knauer M, Hufschmidt M, Burger R, Cejna M, Wenzl E (2006): „Schnittstelle Troikart“ – Endoskopie goes MIC; Eur Surg. Suppl 209:99

 

7.     Knauer M, Konstantiniuk P, Haid A, Riegler-Keil M, Janauer M, Reitsamer R, Köberle-Wührer R, Schrenk P (2006): Multicentric breast cancer as a new indication for sentinel node biopsy – a multiinstitutional validation study; Eur J Cancer.Suppl 4(2):78

 

8.     Knauer M, Konstantiniuk P, Haid A, Riegler-Keil M, Janauer M, Reitsamer R, Wenzl E, Schrenk P (2006): Das Multizentrische Mammakarzinom als neue Indikation zur Sentinel Node Biopsy; Senologie. 3:185-193

 

9.     Knauer M, Haid A, Dunziger S, Jasarevic Z, Köberle-Wührer R, Schuster A, Haid B, Obwegeser U, Offner F, Wenzl E (2007): Intraoperative Sonography: a valuable diagnostic tool in the surgeon´s hand for the operation of non-palpable breast lesions; Eur Surg. Suppl 215:77.

 

10.  Knauer M, Haid A, de Vries A, Schneider Y, Lang A, Winder T, Alton R, Wenzl E (2007): Does combination of neoadjuvant and adjuvant chemotherapy improve outcome in operable breast cancer patients?; Breast Cancer Res Tr. 106 (suppl 1, abstr 5065).

 

11.  Knauer M, Haid A, de Vries A, Schneider Y, Lang A, Winder T, Alton R, Wenzl E (2008): Does combination of neoadjuvant and adjuvant chemotherapy improve outcome in operable breast cancer patients?; Eur Surg. Suppl, Abstract P006.

 

12.  Knauer M, Rottenfusser A, Bartsch R, Dieckmann K, Wenzel C., Fromm S, Eiter H, Steger GG, Zielinski CC, de Vries A (2008): Analysis of risk factors predicting time to development of brain metastases; J Clin Oncol 26: suppl; abstr 1076

 

13.  Knauer M, Retèl V, Bueno-de-Mesquita JM, Rutgers EJT, van Harten WH, Rodenhuis S, van de Vijver MJ, van 't Veer LJ, Linn SC (2008): Benefit of the 70-gene profile for widely used guidelines: an answer to increased selection for adjuvant chemotherapy in breast cancer; Breast Cancer Res Tr. (Suppl), Abstract 1084.

 

14.  Knauer M, Cardoso F, Mook S, Bedard P, Koornstra R, Kok M, Bueno-de-Mesquita JM, Wesseling J, van de Vijver MJ, Linn SC, Rutgers EJT, van 't Veer LJ (2008): Identification of a low risk subgroup in Her2-positive breast cancer by the 70-gene prognosis signature; Breast Cancer Res Tr. (Suppl), Abstract 4171.

 

15.  Knauer M, Rutgers EJT, Mook S, Cardoso F, van de Vijver MJ, Viale G, Glas AM, Saghatchian M, Kok M, Bueno-de-Mesquita JM, Linn SC, van 't Veer LJ (2009): The 70-gene MammaPrint signature for optimal risk stratification in endocrine responsive breast cancer; Breast (Suppl), Abstract 72.

 

16.  Knauer M, Straver ME, Rutgers EJT, Bender RA, Cardoso F, Mook S, van de Vijver MJ, Saghatchian M, Koornstra RHT, Bueno-de-Mesquita JM, Rodenhuis S, Linn SC, van 't Veer LJ (2009): The 70-gene MammaPrint signature is predictive for chemotherapy benefit in early breast cancer; Breast (Suppl), Abstract 73.

 

17.  Knauer M, Mook S, Retèl V, Kok M, Wesseling J,  Glas AM, Rutgers EJ, van 't Veer LJ,  Linn SC (2009): Early determination of metastatic potential in breast cancer: The 70-gene signature in small tumors; J Clin Oncol 27:15s, suppl; abstr 518.

 

18.  Knauer M, Linn SC, van 't Veer LJ, Rutgers EJT (2009): Neue Herausforderungen durch Individualisierung der Therapie: Genexpressionsanalysen beim Mammakarzinom; Senologie 6(2), abstract A64.

 

19.  Knauer M, Mook S, Linn SC, van 't Veer LJ, Rutgers EJT (2009): Das 70-Genexpressionsprofil MammaPrint als prädiktiver Marker für das Ansprechen auf (neo)adjuvante Chemotherapie beim Mammakarzinom; Eur Surg 41, suppl 230, abstract 434.

 

20.  Knauer M, Haid A, Wenzl E, Linn SC, van 't Veer LJ, Rutgers EJT (2009): Anforderungen an die Chirurgie durch Individualisierung der Therapie mittels Genexpressionsanalyse beim Mammakarzinom; Eur Surg 41, suppl 230, abstract 504.

 

21.  Knauer M, Mook S, Linn SC, van 't Veer LJ, Rutgers EJT (2010): Das 70-Genprofil MammaPrint als prädiktiver Marker für das Ansprechen auf (neo)adjuvante Chemotherapie beim Mammakarzinom, Deutscher Krebskongress, Onkologie 33, suppl 2, abstract FV114.

 

22.  Knauer M, Rutgers EJT, Mook S, Wesseling J, van 't Veer LJ (2010): The 70-gene signature predicts prognosis of breast cancer patients independently from histological grade; J Clin Oncol 28:15s, (suppl; abstr 561)

 

23.  Knauer M, Köberle-Wührer R, Jasarevic Z, Obwegeser U, Wenzl E, Haid A (2010): Intraoperative ultrasound for improvement of re-excision rates in breast conserving surgery; Eur J Surg Oncol 36(9),abstract 13.

 

24.  Haid A, Konstantiniuk P, Köberle-Wührer R, Burtscher J, Knauer M, Zimmermann G (2002): Beurteilung der Schulter-Arm-Morbidität nach Axilladissektion und alleiniger Sentinel Node Biopsy beim Mammakarzinom nach dem Summenscore von T.Kühn et al.; Eur Surg 2002:34:Suppl.183:100

 

25.  Ammann K, Köberle-Wührer R, Knauer M, Wenzl E, Haid A (2006): Follow-up data after sentinel node biopsy alone for breast cancer; Eur Surg 2006:Suppl 209:19

 

26.  Esserman LJ, van't Veer LJ, Perou C, Rutgers EJT, Knauer M, Davis SE, I-SPY Investigators, on Behalf of the I-SPY TRIAL Network (2008): Biology of breast cancers that present as interval cancers and at young age should inform how we approach early detection and prevention;Breast Cancer Res Tr 2008 (Suppl), Abstract 6034.

 

27.  Saghatchian M, Mook S, Pruneri G, Viale G, Glas AM, Eekhout I, Knauer M, van 't Veer LJ (2009): The 70-gene MammaPrint profile allows to identify a subgroup of good prognostic patients with primary breast cancer and 4-9 positive lymph nodes; Breast 2009 (Suppl), Abstract 71.

 

28.  Bender RA, Knauer M, Rutgers EJ, Glas AM, de Snoo FA, Linn SC, Van 't Veer LJ (2009): The 70-gene profile and chemotherapy benefit in 1,600 breast cancer patients; J Clin Oncol 27:15s, 2009 (suppl; abstr 512).

 

29.  de Snoo FA, Knauer M, Bender RA, Stork-Sloots L, Rutgers EJ, Glas AM, Linn SC, Van 't Veer LJ (2009): Outcome prediction by the 70-gene profile in the context of the National Comprehensive Cancer Network (NCCN) guidelines; J Clin Oncol 27:15s, 2009 (suppl; abstr 535).

 

30.  Van 't Veer LJ, Esserman LJ, Linn S, Rutgers E, Knauer M, Retel V, Davis SE,  Lin C (2009): Evaluation of the effect of screening on the detection of good and poor prognosis breast cancers; J Clin Oncol 27:15s, 2009 (suppl; abstr 1525).

 

31.  Haid A, Köberle-Wührer R, Knauer M, Obwegeser U, Wenzl E (2009): Zur Anwendung der intraoperativen Sonografie bei der Chirurgischen Behandlung des Mammakarzinoms Eur Surg 41, suppl 230, abstract 437.

 

32.  Obwegeser U, Haid A, Köberle-Wührer R, Knauer M, Thurnes O, Wenzl E (2009): Axilläre Lymphknoten-Metastasen beim primär okkulten Mammakarzinom; Eur Surg 41, suppl 230, abstract 435.

 

33.  Bedard PL, Mook S, Knauer M, Durbecq V, Bernard-Marty C, Glas AM, Cardoso F, van ‘t Veer LJ (2009): The 70-gene Profile (MammaPrint) Is an Independent Predictor of Breast Cancer Specific Survival for Women 65 Years of Age or Older; Cancer Research 2009;69(Suppl.): abstract 4049.

 

34.  Shieh Y, Esserman LJ, Rutgers EJT, Knauer M, Retel VP, Mook S, Glas AM, Moore DH, Linn SC, van Leeuwen FE, van ‘t Veer LJ (2010): Effect of screening on the detection of good and poor prognosis breast cancers; J Clin Oncol 28:15s, 2010 (suppl; abstr 1520)